Dorsey Wright & Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100,933
Closed -$2.93M 286
2021
Q3
$2.93M Sell
100,933
-527
-0.5% -$17.1K 0.64% 69
2021
Q2
$3.53M Sell
101,460
-307
-0.3% -$10.2K 0.75% 56
2021
Q1
$2.84K Buy
101,767
+87,466
+612% +$2.33M 0.03% 224
2020
Q4
$355K Buy
+14,301
New +$340K 0.05% 144
2018
Q1
Sell
-27,441
Closed -$1.37M 120
2017
Q4
$1.37M Buy
+27,441
New +$1.44M 0.25% 98

Other funds holding CC

Dorsey Wright & Associates's CC Position: Q4 2021 in Review

Dorsey Wright & Associates sold out of Chemours (CC) in Q4 2021, closing a stake of 100,933 shares — an estimated $2.93M sold.

Dorsey Wright & Associates first reported a position in CC in Q4 2017 and held it in 5 quarters. The position peaked at $3.53M in Q2 2021. 504 funds tracked by Wall St. Rank hold CC as of Q4 2021.

  • Dorsey Wright & Associates reported no remaining Chemours position as of Q4 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 100,933 Chemours shares in Q4 2021, an estimated $2.93M.
  • Dorsey Wright & Associates first reported a position in Chemours in Q4 2017 and held it in 5 quarters.
  • Dorsey Wright & Associates's Chemours position peaked at $3.53M in Q2 2021.
  • 504 funds tracked by Wall St. Rank held Chemours as of Q4 2021.

Based on Dorsey Wright & Associates's 13F filing for Q4 2021, filed 27 Jan 2022.